Several urinary biomarkers such as N-acetyl-β-d-glucosaminidase, β2-microglobulin, and neutrophil gelatinase-associated lipocalin have been used as indicators of kidney injury. The gene discussed is LCN2; the disease is urogenital neoplasm.